AzTrials
AzTrials

Smoking Cessation InterventionNCT02539875

Promoting Smoking Cessation in the Community Via QTW 2015

A study testing AWARD and brief leaflet/ Referral leaflet and active referral/ Smoking cessation booklet and general advices in people with Smoking Cessation Intervention, run by The University of Hong Kong at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Although smoking prevalence is decreasing in Hong Kong, there are still 648,800 daily smokers 10.8% (Census and Statistics Department, 2013) and half will be killed by smoking (Lam, 2012) which accounts for over 7,000 deaths per year (Lam, Ho, Hedley, Mak, \& Peto, 2001). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Smoking Cessation Intervention
What is being tested?
AWARD and brief leaflet/ Referral leaflet and active referral/ Smoking cessation booklet and general advices
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,306 participants
Where
1 siteChina
Study dates
1 Jun 2015to 30 Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Hong Kong residents aged 18 or above
  • Smoke at least 1 cigarette per day in the past 3 months
  • Able to communicate in Cantonese
  • Exhaled carbon monoxide (CO) 4 ppm or above, assessed by a validated CO smokerlyzer
  • Have Intention to quit

Who cannot join

  • Smokers who have difficulties (either physical or cognitive condition) to communicate
  • Currently following other smoking cessation programs

Trial locations and contacts

1 site in 1 country.

China1 site
  • The Hong Kong Council on Smoking and Health (COSH)

    Hong Kong

Other trials in China

About this study

Official title: Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2015: a Randomized Controlled Trial on Brief Intervention (AWARD Model) and Active Referral to Smoking Cessation Services

Although smoking prevalence is decreasing in Hong Kong, there are still 648,800 daily smokers 10.8% (Census and Statistics Department, 2013) and half will be killed by smoking (Lam, 2012) which accounts for over 7,000 deaths per year (Lam, Ho, Hedley, Mak, \& Peto, 2001). Smoking also accounts for a large amount of medical cost, long-term care and productivity loss of US$688 million (0.6% Hong Kong GDP) (Census \& Statistics Department, 2001; McGhee et al., 2006) . Smoking is a highly addictive behavior and it is difficult for smokers with strong nicotine dependence to quit without assistance. On the other hand, reaching and helping the many smokers who have no intention to quit is a challenge, because they are unlikely to seek professional help from smoking cessation services.

The Quit and Win programme provides an opportunity to reach and encourage a large group of smokers to make quit attempt and maintain abstinence. The Quit and Win model posits that smokers participating in the contest will have higher motivation to quit with incentives and better social support (Cahill \& Perera, 2011). Studies have found that such quitting contests or incentive programs appeared to reach a large number of smokers and demonstrated a significantly higher quit rate for the quit and win group than for the control group (Cahill \& Perera, 2008).

Read more

Smoking cessation services in Hong Kong are under-used with more than half (60.9%) adult daily smokers who had never used smoking cessation services (Census and Statistics Department, 2013). Among these smokers only 9.6% were willing to use the services. Existing services mostly require self-initiation to seek the services but smokers general lack the will power of initiation. Active referral will help overcome the barriers of self-initiation. There is preliminary evidence that active referral of smokers to smoking cessation hotline services may increase likelihood of smoking abstinence at 12-month follow-up compared with no active referrals (Borland et al., 2008). A recent study has also reported that individuals who used the community-based referral were also more likely to quit than those who did not (43.6% vs 15.3%, P<0.001) (Haas et al., 2015).

Therefore, the present study will examine (1) effectiveness of the active referral and AWARD approaches, (2) explore the use of CBPR model to build capacity and to engage community partners in taking on this important public health issue for sustainability in the community. In addition, process evaluation will be conducted to assess the effectiveness of the recruitment activity and how it is linked with the overall program outcomes.

Being tested
AWARD and brief leaflet/ Referral leaflet and active referral/ Smoking cessation booklet and general advices
Keywords
Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AWARD and brief leaflet/ Referral leaflet and active referral/ Smoking cessation booklet and general advicesBehavioural

    Use AWARD and brief leaflet/ Referral leaflet and active referral/ Smoking cessation booklet and general advices interventions to achieve smoking abstinence

Study groups in NCT02539875
Study groupRoleWhat they receive
AWARD, Brief leaflet, Referral leaflet, active referralExperimentalAWARD will be delivered to smokers onsite and this includes: Ask about smoking history, Warn about the high risk, Advise to quit as soon as possible and not later than a quit date (which will qualify them for the QTW prizes), Refer smokers to smoking cessation services, and Do it again: to repeat the intervention. Brief innovative leaflet on health warning and smoking cessation. A 2-side color printed A4 leaflet will be designed to systematically cover the most important messages to motivate smoking cessation. A 2-side color printed A4 referral leaflet will be used for motivate and assist the smokers to use the smoking cessation services. the smokers will be active refer to various smoking cessation services in Hong Kong (using the referral leaflet) and motivate the smokers to use the smoking cessation services.
Receives: Behavioral: AWARD and brief leaflet/ Referral leaflet and active referral/ Smoking cessation booklet and general advices
AWARD, Brief leafletExperimentalAWARD will be delivered to smokers onsite and this includes: Ask about smoking history, Warn about the high risk, Advise to quit as soon as possible and not later than a quit date (which will qualify them for the QTW prizes), Refer smokers to smoking cessation services, and Do it again: to repeat the intervention. Brief innovative leaflet on health warning and smoking cessation. A 2-side color printed A4 leaflet will be designed to systematically cover the most important messages to motivate smoking cessation.
Receives: Behavioral: AWARD and brief leaflet/ Referral leaflet and active referral/ Smoking cessation booklet and general advices
Smoking cessation booklet, general advicesActive comparatorParticipants will receive minimal intervention, including: (1) the 12-page smoking cessation booklet (provided by COSH); (2) very brief, minimal and general smoking cessation advice include: "Please quit smoking for improving health and save money", "Please refer to the booklet for the details about smoking cessation" and "Please call us if you have any enquiry".
Receives: Behavioral: AWARD and brief leaflet/ Referral leaflet and active referral/ Smoking cessation booklet and general advices

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. smoking quit rate change from baseline at 3-month follow-up

    The primary outcomes are self-reported 7-day point prevalence (pp) quit rate at 3 and 6 months among the two groups

    Measured: 3-month follow-up

  2. smoking quit rate change from baseline at 6-month follow-up

    The primary outcomes are self-reported 7-day point prevalence (pp) quit rate

    Measured: 6-month follow-up

Secondary outcomes (12)
  1. Biochemical validated quit rate

    biochemically validated quit rates at 3 month in the two groups

    Measured: 3-month follow-up

  2. Biochemical validated quit rate

    biochemically validated quit rates at 6 month in the two groups

    Measured: 6-month follow-up

  3. Smoking reduction rate change from baseline at 3-month follow-up

    rate of smoking reduction by at least half of baseline amount in the two groups

    Measured: 3-month follow-up

  4. Smoking reduction rate change from baseline at 6-month follow-up

    rate of smoking reduction by at least half of baseline amount in the two groups

    Measured: 6-month follow-up

  5. Smoking quit attempt change from baseline at 3-month follow-up

    number of quit attempts at 3 month among the two groups

    Measured: 3-month follow-up

  6. Smoking quit attempt change from baseline at 6-month follow-up

    number of quit attempts at 6 month among the two groups

    Measured: 6-month follow-up

  7. quit rate for all subjects change from baseline at 3-month follow-up

    the above cessation and reduction outcomes of all subjects participating in Quit to Win contest 2015

    Measured: 3-month follow-up

  8. Reduction rate for all subjects change from baseline at 3-month follow-up

    the above cessation and reduction outcomes of all subjects participating in Quit to Win contest 2015

    Measured: 3-month follow-up

  9. quit rate for all subjects change from baseline at 6-month follow-up

    the above cessation and reduction outcomes of all subjects participating in Quit to Win contest 2015

    Measured: 6-month follow-up

  10. Reduction rate for all subjects change from baseline at 6-month follow-up

    the above cessation and reduction outcomes of all subjects participating in Quit to Win contest 2015

    Measured: 6-month follow-up

  11. quit rate for all subjects change from baseline at 12-month follow-up

    the above cessation and reduction outcomes of all subjects participating in Quit to Win contest 2015

    Measured: 12-month follow-up

  12. Reduction rate for all subjects change from baseline at 12-month follow-up

    the above cessation and reduction outcomes of all subjects participating in Quit to Win contest 2015

    Measured: 12-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2015 (estimated)
  2. Study start1 Jun 2015
  3. Primary completion30 Apr 2016
  4. Study completion30 Apr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
1,306 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02539875
Sponsor's protocol ID
QTW2015
Status last verified
Nov 2016
First submitted
22 Jul 2015
Last updated
26 Oct 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Undecided

Publications

  • Zeng Y, Wu YS, Luk TT, Zhao SZ, Guo Z, Li Y, Tong HSC, Lai VWY, Cheung YTD, Lam TH, Wang MP. Quitting trajectories of Hong Kong Chinese smokers receiving behavioral smoking cessation interventions: A post hoc analysis of eight randomized controlled trials. Addiction. 2026 Jun;121(6):1568-1579. doi: 10.1111/add.70328. Epub 2026 Jan 17.

    PubMed 41546550
  • Theodoulou A, Fanshawe TR, Leavens E, Theodoulou E, Wu AD, Heath L, Stewart C, Nollen N, Ahluwalia JS, Butler AR, Hajizadeh A, Thomas J, Lindson N, Hartmann-Boyce J. Differences in the effectiveness of individual-level smoking cessation interventions by socioeconomic status. Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD015120. doi: 10.1002/14651858.CD015120.pub2.

    PubMed 39868569
  • Wang MP, Suen YN, Li WH, Lam CO, Wu SY, Kwong AC, Lai VW, Chan SS, Lam TH. Intervention With Brief Cessation Advice Plus Active Referral for Proactively Recruited Community Smokers: A Pragmatic Cluster Randomized Clinical Trial. JAMA Intern Med. 2017 Dec 1;177(12):1790-1797. doi: 10.1001/jamainternmed.2017.5793.

    PubMed 29059277
  • Suen YN, Wang MP, Li WH, Kwong AC, Lai VW, Chan SS, Lam TH. Brief advice and active referral for smoking cessation services among community smokers: a study protocol for randomized controlled trial. BMC Public Health. 2016 May 11;16:387. doi: 10.1186/s12889-016-3084-z.

    PubMed 27169630

Questions about this trial

What is this clinical trial studying?

A study testing AWARD and brief leaflet/ Referral leaflet and active referral/ Smoking cessation booklet and general advices in people with Smoking Cessation Intervention, run by The University of Hong Kong at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

smoking quit rate change from baseline at 3-month follow-up (time frame: 3-month follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02539875, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in